Michelle Mazuranic, Ph.D., R.D., is Vice President of Medical and Regulatory Affairs at ProSciento, Inc. She oversees ProSciento’s medical affairs and regulatory consulting services, as well as works with clients to build strategic clinical development programs from early engagement assessment and planning through the completion of multi-site clinical trials.
Dr. Mazuranic has extensive experience in building and leading global scientific strategies for clinical development, regulatory and medical affairs. Prior to joining ProSciento, Dr. Mazuranic served as Head of Global Medical Affairs at Gan & Lee Pharmaceuticals, where she built the department from the ground up. Prior to that, she served as Director of Global Medical Affairs for the Cardio-Renal and Metabolism Team for a seven-year tenure at AstraZeneca, where she managed strategic relationships with external scientific, academic, and advocacy group organizations and experts. Throughout her career, Dr. Mazuranic has developed and implemented activities to support global and compound-specific strategies, external scientific engagement, medical excellence, and evidence generation. Dr. Mazuranic is a licensed dietitian, completed her M.S. in management from Boston University, and earned her Ph.D. in Public Health and Epidemiology from Walden University.
